MadhavanV.PillaiMD

Oncology • Philadelphia, PA

Professor, Medical Oncology, Jefferson Medical College-Thos Jefferson Univ

Join to view full profile

Dr. Pillai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pillai's full profile

Already have an account?

Office
925 Chestnut St
Ste 320A
Philadelphia, PA 19107
Phone+1 215-955-8874

Fax+1 215-955-2340

Education & Training

Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 1979 - 1982
University of Kerala Medical CollegeClass of 1966

Certifications & Licensure

TX State Medical License 2014 - 2026
PA State Medical License 2010 - 2024
ID State Medical License 2016 - 2020
VA State Medical License 1980 - 2014
DC State Medical License 1989 - 2002
MD State Medical License 1991 - 1999
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Clinical Trials

A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective Start of enrollment: 2012 Sep 01
Completed
Phase 1, Phase 2

Publications & Presentations

PubMed

326 citations
Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on S...
Mario E. Lacouture, Edith P. Mitchell, Bilal Piperdi, Madhavan V. Pillai, Heather Shearer
Journal of Clinical Oncology. 2010-03-10
28 citations
The efficacy and safety of panitumumab administered concomitantly with FOLFIRI or Irinotecan in second-line therapy for metastatic colorectal cancer: the secondary ana...
Edith P. Mitchell, Bilal Piperdi, Mario E. Lacouture, Heather Shearer, Nicholas Iannotti
Clinical Colorectal Cancer. 2011-12-01
48 citations
A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgras...
J. Randolph Hecht, Madhavan V. Pillai, Russell Gollard, William Heim, Forrest Swan
Clinical Colorectal Cancer. 2010-04-01